See All Slides - tctmd.com

Slides

Presentation TCT 2012

The New European STEMI Guidelines: What Are the Differences from U.S. Guidelines and Why?

Presenter: Christian Hamm

October 26, 2012

Presentation TCT 2012

The Importance of Frailty Assessments in TAVR Patient Screening

Presenter: Philip Green

October 26, 2012

Presentation TCT 2012

How to Maximize Practice Performance in Large Practices: Independent or Hospital Integrated? Generalist or Subspecialization? Equal Split or Productivity Based? And More

Presenter: Eric Dippel

October 26, 2012

Presentation TCT 2012

Do We Need Payment Incentives to Optimize STEMI Networks?

Presenter: Ivan Rokos

October 26, 2012

Presentation TCT 2012

Keynote Lecture 1: What Is a “Heart Team” and Why Is it Essential for a Successful TAVR Program?

Presenter: Nicolo Piazza

October 26, 2012

Presentation TCT 2012

A Guide to Hydration Modalities: Normal Saline vs. Bicarbonate, Timing, and Duration

Presenter: Carlo Briguori

October 26, 2012

Presentation TCT 2012

Case 1: Patient with Stable Class 1 Angina Treated with Aspirin and Statin and a Mid LAD 70% Stenosis(2)

Presenter: Megan Coylewright

October 26, 2012

Presentation TCT 2012

XIMA: A Prospective, Randomized Trial of Everolimus-Eluting Stents vs. Bare-Metal Stents in Octogenarians

Presenter: Adam de Belder

October 26, 2012

Presentation TCT 2012

Case 1: Subacute DES Thrombosis After Elective PCI (with Imaging)

Presenter: Francesco Prati

October 26, 2012

Presentation TCT 2012

A Surgeon's Perspective on TAVR Clinical Use Patterns in Europe

Presenter: Neil Moat

October 26, 2012

Advertisement

Slides

The New European STEMI Guidelines: What Are the Differences from U.S. Guidelines and Why?

The Importance of Frailty Assessments in TAVR Patient Screening

How to Maximize Practice Performance in Large Practices: Independent or Hospital Integrated? Generalist or Subspecialization? Equal Split or Productivity Based? And More

Do We Need Payment Incentives to Optimize STEMI Networks?

Keynote Lecture 1: What Is a “Heart Team” and Why Is it Essential for a Successful TAVR Program?

A Guide to Hydration Modalities: Normal Saline vs. Bicarbonate, Timing, and Duration

Case 1: Patient with Stable Class 1 Angina Treated with Aspirin and Statin and a Mid LAD 70% Stenosis(2)

XIMA: A Prospective, Randomized Trial of Everolimus-Eluting Stents vs. Bare-Metal Stents in Octogenarians

Case 1: Subacute DES Thrombosis After Elective PCI (with Imaging)

A Surgeon's Perspective on TAVR Clinical Use Patterns in Europe

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content